{"id":14381,"date":"2025-01-31T10:14:55","date_gmt":"2025-01-31T10:14:55","guid":{"rendered":"https:\/\/www.drfz.de\/?post_type=project&p=14381"},"modified":"2025-03-30T17:27:16","modified_gmt":"2025-03-30T17:27:16","slug":"improving-the-health-of-children-and-adolescents-with-autoinflammatory-diseases-aid","status":"publish","type":"project","link":"https:\/\/www.drfz.de\/en\/forschungsprojekte\/improving-the-health-of-children-and-adolescents-with-autoinflammatory-diseases-aid\/","title":{"rendered":"Improving the health of children and adolescents with autoinflammatory diseases (Pro-AID)"},"content":{"rendered":"\n
\n
\n

Cooperation partners<\/h2>\n \n
PRO-AID is a sub-project of the PRO-Kind initiative of the GKJR, which promotes effective diagnostics and targeted treatment of rheumatic diseases in children and adolescents.
\r\nThe PRO-AID consortium includes the PRO-Kind consortium and those responsible for the development of the consensus-based protocols: the DRFZ, the University Children’s Hospital of Basel, the Autoinflammation Reference Center T\u00fcbingen (arcT), the Department of Pediatrics and Adolescent Medicine at RWTH Aachen University, the Asklepios Clinic Sankt Augustin, the University Hospital M\u00fcnster, and the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Department of Pediatrics, Division of Pneumology, Immunology and Intensive Care.
\r\nPatient representatives from the Deutsche Rheuma-Liga and the FMF & AID Global Association are actively involved in the project. The network is currently cooperating with 11 pediatric rheumatology centers.
\r\n
\r\n
\r\n<\/div>\n \n
\n